http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103142538-B
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2b1fbc33d49dafd622558b0c949e63e6 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-715 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 |
| filingDate | 2013-03-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2014-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_246589ca62a7bc64488a1dcd74bbc2ef http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a5aad02153ef20fdb37d75360be14c8b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6af0d386c07b115a3c05debea422c5f3 |
| publicationDate | 2014-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-103142538-B |
| titleOfInvention | PGMS (Propylene Glycol Mannate Sulfate) enteric tablet and preparation method thereof |
| abstract | The invention discloses a PGMS (Propylene Glycol Mannate Sulfate) enteric tablet and a preparation method thereof. The PGMS enteric tablet disclosed by the invention consists of a PGMS tablet core and an enteric coating layer coated outside the PGMS tablet core, wherein the PGMS tablet core comprises PGMS, filler and a disintegrant, and the enteric coating layer comprises an enteric material, a plasticizer, an antisticking agent and an opacifier; and during preparation, the PGMS enteric tablet is prepared through coating the enteric coating layer outside the PGMS tablet core. According the PGMS enteric tablet and the preparation method of the PGMS enteric tablet, the enteric effect is ideal, the bioavailability can be improved, and the stimulation to gastric mucosa caused by the drug is reduced; and the preparation method is simple, the quality of obtained products is stable, and thus, the method is applicable to large-scale production application. |
| priorityDate | 2013-03-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 39.